-
1
-
-
57349138859
-
Hypertension and proteinuria: A class-effect of antiangiogenic therapies
-
Launay-Vacher V, Deray G: Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Anticancer Drugs 2009; 20: 81-82.
-
(2009)
Anticancer Drugs
, vol.20
, pp. 81-82
-
-
Launay-Vacher, V.1
Deray, G.2
-
2
-
-
33645451829
-
Angiogenesis inhibitors and hypertension: An emerging issue
-
Sica DA: Angiogenesis inhibitors and hypertension: an emerging issue. J Clin Oncol 2006; 24: 1329-1331.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1329-1331
-
-
Sica, D.A.1
-
3
-
-
23644439061
-
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
-
Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K: Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005; 115: 2108-2118.
-
(2005)
J Clin Invest
, vol.115
, pp. 2108-2118
-
-
Shiojima, I.1
Sato, K.2
Izumiya, Y.3
Schiekofer, S.4
Ito, M.5
Liao, R.6
Colucci, W.S.7
Walsh, K.8
-
4
-
-
31744444218
-
Novel integrative approaches to the identification of candidate genes in hypertension
-
Hubner N, Yagil C, Yagil Y: Novel integrative approaches to the identification of candidate genes in hypertension. Hypertension 2006; 47: 1-5.
-
(2006)
Hypertension
, vol.47
, pp. 1-5
-
-
Hubner, N.1
Yagil, C.2
Yagil, Y.3
-
5
-
-
78649953614
-
Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: Mechanisms and potential use as a biomarker
-
Robinson ES, Khankin EV, Karumanchi SA, Humphreys BD: Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker. Semin Nephrol 2010; 30: 591-601.
-
(2010)
Semin Nephrol
, vol.30
, pp. 591-601
-
-
Robinson, E.S.1
Khankin, E.V.2
Karumanchi, S.A.3
Humphreys, B.D.4
-
6
-
-
66449096999
-
Powik?ania kardiologiczne jako powik?ania terapii celowanych
-
Szmit S, Opolski G, Szczylik C: Powik?ania kardiologiczne jako powik?ania terapii celowanych. Współczesna Onkol 2008; 12: 7: 318-323.
-
(2008)
Współczesna Onkol
, vol.12
, Issue.7
, pp. 318-323
-
-
Szmit, S.1
Opolski, G.2
Szczylik, C.3
-
7
-
-
84856223555
-
Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib
-
Szmit S, Nurzynski P, Szalus N, Opolski G, Szczylik C: Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib. Acta Oncol 2009; 4: 1-5.
-
(2009)
Acta Oncol
, vol.4
, pp. 1-5
-
-
Szmit, S.1
Nurzynski, P.2
Szalus, N.3
Opolski, G.4
Szczylik, C.5
-
8
-
-
58149098429
-
Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
-
Zhu X, Stergiopoulos K, Wu S: Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis. Acta Oncol 2009; 48: 9-17.
-
(2009)
Acta Oncol
, vol.48
, pp. 9-17
-
-
Zhu, X.1
Stergiopoulos, K.2
Wu, S.3
-
9
-
-
84856228015
-
Association of diastolic blood pressure 1 90 mm Hg with overall survival in patients treated with axitinib
-
abstr 3543
-
Rini BI, Schiller JH, Fruehauf JP, Cohen EE, Tarazi JC, Rosbrook B, Ricart AD, Olszanski AJ, Kim S, Spano J: Association of diastolic blood pressure 1 90 mm Hg with overall survival in patients treated with axitinib. J Clin Oncol 2008; 26: 15S, abstr 3543.
-
(2008)
J Clin Oncol
, vol.26
-
-
Rini, B.I.1
Schiller, J.H.2
Fruehauf, J.P.3
Cohen, E.E.4
Tarazi, J.C.5
Rosbrook, B.6
Ricart, A.D.7
Olszanski, A.J.8
Kim, S.9
Spano, J.10
-
10
-
-
77954472714
-
Biomarkers: Hypertension following anti-angiogenesis therapy
-
Rini BI: Biomarkers: Hypertension following anti-angiogenesis therapy. Clin Adv Hematol Oncol 2010; 8: 415-416.
-
(2010)
Clin Adv Hematol Oncol
, vol.8
, pp. 415-416
-
-
Rini, B.I.1
-
11
-
-
34247480545
-
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
-
Force T, Krause DS, Van Etten R: Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 2007; 7: 332-344.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 332-344
-
-
Force, T.1
Krause, D.S.2
Van Etten, R.3
-
12
-
-
4644354183
-
Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer experience
-
Motzer RJ, Bacik J, Mazumdar M: Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer experience. Clin Cancer Res 2004; 15: 6302S-6303S.
-
(2004)
Clin Cancer Res
, vol.15
-
-
Motzer, R.J.1
Bacik, J.2
Mazumdar, M.3
-
13
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
14
-
-
5644240939
-
The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: The ICARe Dicomano Study
-
Di Bari M, Pozzi C, Cavallini MC, Innocenti F, Baldereschi G, De Alfieri W, Antonini E, Pini R, Masotti G, Marchionni N: The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J Am Coll Cardiol 2004; 44: 1601-1608.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1601-1608
-
-
Di Bari, M.1
Pozzi, C.2
Cavallini, M.C.3
Innocenti, F.4
Baldereschi, G.5
De Alfieri, W.6
Antonini, E.7
Pini, R.8
Masotti, G.9
Marchionni, N.10
-
15
-
-
0037527647
-
European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension
-
European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1153.
-
(2003)
J Hypertens
, vol.2003
, Issue.21
, pp. 1011-1153
-
-
-
16
-
-
12444277817
-
On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
-
O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
-
(2003)
J Hypertens
, vol.21
, pp. 821-848
-
-
O'brien, E.1
Asmar, R.2
Beilin, L.3
Imai, Y.4
Mallion, J.M.5
Mancia, G.6
Mengden, T.7
Myers, M.8
Padfield, P.9
Palatini, P.10
Parati, G.11
Pickering, T.12
Redon, J.13
Staessen, J.14
Stergiou, G.15
Verdecchia, P.16
-
17
-
-
79955623124
-
Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
-
Bono P, Rautiola J, Utriainen T, Joensuu H: Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma. Acta Oncol 2011; 50: 569-573.
-
(2011)
Acta Oncol
, vol.50
, pp. 569-573
-
-
Bono, P.1
Rautiola, J.2
Utriainen, T.3
Joensuu, H.4
-
18
-
-
60549095633
-
Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma
-
Bono P, Elfving H, Utriainen T, Osterlund P, Saarto T, Alanko T, Joensuu H: Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma. Ann Oncol 2009;20:393-394.
-
(2009)
Ann Oncol
, vol.20
, pp. 393-394
-
-
Bono, P.1
Elfving, H.2
Utriainen, T.3
Osterlund, P.4
Saarto, T.5
Alanko, T.6
Joensuu, H.7
-
19
-
-
53849134160
-
Anti-angiogenic treatment in the management of metastatic renal cell carcinoma
-
Sire M, Wallerand H, Kilkoski F, Grenier N, Ferriere JM, Ravaud A: Anti-angiogenic treatment in the management of metastatic renal cell carcinoma. Bull Cancer 2008; 95: 813-820.
-
(2008)
Bull Cancer
, vol.95
, pp. 813-820
-
-
Sire, M.1
Wallerand, H.2
Kilkoski, F.3
Grenier, N.4
Ferriere, J.M.5
Ravaud, A.6
-
20
-
-
39349107170
-
Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition
-
Weikert S, Boeing H, Pischon T, et al: Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol 2008; 167: 438-446.
-
(2008)
Am J Epidemiol
, vol.167
, pp. 438-446
-
-
Weikert, S.1
Boeing, H.2
Pischon, T.3
-
21
-
-
69849085146
-
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: A multicenter analysis
-
Di Lorenzo G, Autorino R, Bruni G, et al: Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis. Ann Oncol 2009; 20: 1535-1542.
-
(2009)
Ann Oncol
, vol.20
, pp. 1535-1542
-
-
Di Lorenzo, G.1
Autorino, R.2
Bruni, G.3
-
22
-
-
55949123335
-
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma
-
Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H: Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 2008; 26: 5204-5212.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5204-5212
-
-
Schmidinger, M.1
Zielinski, C.C.2
Vogl, U.M.3
Bojic, A.4
Bojic, M.5
Schukro, C.6
Ruhsam, M.7
Hejna, M.8
Schmidinger, H.9
-
23
-
-
0347423198
-
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
24
-
-
34548383480
-
ESH-ESC task force on the management of arterial hypertension
-
Mancia G, De Backer G, Dominiczak A, et al: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751-1762.
-
(2007)
J Hypertens
, vol.25
, pp. 1751-1762
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
|